Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4891 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4816 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2806 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-204 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4833 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 |
filingDate |
2018-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2020-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2020506918-A |
titleOfInvention |
Controlled release dosage forms at specific gastrointestinal sites |
abstract |
Controlled release dosage forms at specific gastrointestinal sites are provided. The dosage form comprises a shell defining first and second compartments, a first active pharmaceutical ingredient (API) loaded in the first compartment, and a second API loaded in the second compartment. And the first API and the second API may be the same or different. The shell includes a first material that melts at a first gastrointestinal site and a second material that melts at a second gastrointestinal site. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11571391-B2 |
priorityDate |
2017-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |